InsiderTrades.com logo
This is the worst sign for the U.S. stock market in 50 years
From Stansberry Research   |   Ad
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Click here to see Dan's new, urgent warning about the U.S. market for 2025.

BIVI Insider Trading

Insider Ownership Percentage: 4.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

BioVie Insider Trading History Chart

This chart shows the insider buying and selling history at BioVie by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioVie Share Price & Price History

Current Price: $1.90
Price Change: ▼ Price Decrease of -0.18 (-8.65%)
As of 12/20/2024 06:31 PM ET

This chart shows the closing price history over time for BIVI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
⭕ [URGENT] Buy Alert just triggered
From Behind the Markets   |   Ad
My absolute favorite stock just hit a critical "buy now" trigger price.
Click here for the ticker >>>

BioVie Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2023Cuong V DoCEOBuy10,000$1.78$17,800.0068,759View SEC Filing Icon  
9/5/2023Steve GorlinDirectorSell8,560$3.05$26,108.0075,680View SEC Filing Icon  
8/22/2023Richard J BermanDirectorSell10,805$3.50$37,817.5016,789View SEC Filing Icon  
6/7/2023Richard J BermanDirectorSell5,984$5.81$34,767.0423,210View SEC Filing Icon  
5/22/2023Richard J BermanDirectorSell5,000$6.50$32,500.0029,194View SEC Filing Icon  
3/27/2023Richard J BermanDirectorSell3,371$8.52$28,720.9241,807View SEC Filing Icon  
See Full Table
This is the worst sign for the U.S. stock market in 50 years
From Stansberry Research   |   Ad
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Click here to see Dan's new, urgent warning about the U.S. market for 2025.

SEC Filings (Institutional Ownership Changes) for BioVie (NASDAQ:BIVI)

4.59% of BioVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BIVI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioVie Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2024Sheaff Brock Investment Advisors LLC51,400$27K0.0%+276.9%0.129%Search for SEC Filing on Google Icon
5/7/2024CVI Holdings LLC599,897$0.32M0.3%N/A1.503%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC10,000$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
10/30/2023Summit Trail Advisors LLC10,100$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
10/25/2023Crescent Grove Advisors LLC11,000$38K0.0%N/A0.030%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp15,955$54K0.0%-51.2%0.043%Search for SEC Filing on Google Icon
8/29/2023Garde Capital Inc.24,163$0.10M0.0%+40.8%0.066%Search for SEC Filing on Google Icon
7/20/2023AJ Wealth Strategies LLC23,474$0.10M0.0%+52.2%0.065%Search for SEC Filing on Google Icon
7/11/2023FNY Investment Advisers LLC8,986$38K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC54,117$0.44M0.0%+117.7%0.150%Search for SEC Filing on Google Icon
4/28/2023AJ Wealth Strategies LLC15,428$0.13M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/24/2023Garde Capital Inc.17,163$0.13M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC16,110$0.13M0.0%N/A0.053%Search for SEC Filing on Google Icon
2/14/2023swisspartners Ltd.294,346$2.29M2.9%+82.8%0.964%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC12,175$94K0.0%N/A0.040%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can10,000$78K0.0%N/A0.033%Search for SEC Filing on Google Icon
1/30/2023International Assets Investment Management LLC10,500$82K0.0%N/A0.034%Search for SEC Filing on Google Icon
1/10/2023FNY Investment Advisers LLC14,200$0.11M0.2%N/A0.047%Search for SEC Filing on Google Icon
11/15/2022Pura Vida Investments LLC36,617$91K0.0%N/A0.120%Search for SEC Filing on Google Icon
5/4/2022swisspartners Ltd.10,367$1.87M1.3%-87.1%0.042%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC20,000$90K0.0%N/A0.080%Search for SEC Filing on Google Icon
11/16/2021swisspartners Ltd.80,521$0.54M0.4%+45.0%0.323%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC53,100$0.36M0.0%+90.3%0.214%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC27,900$0.47M0.0%N/A0.200%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC22,898$0.39M0.0%+8.0%0.164%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.97,804$1.66M0.0%+267.6%0.700%Search for SEC Filing on Google Icon
8/11/2021swisspartners Ltd.55,521$0.94M0.7%+2.2%0.397%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC23,107$0.45M0.0%-3.7%0.166%Search for SEC Filing on Google Icon
5/17/2021Ameriprise Financial Inc.90,876$1.76M0.0%N/A0.651%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC21,200$0.41M0.0%N/A0.152%Search for SEC Filing on Google Icon
5/12/2021swisspartners Ltd.54,300$1.05M0.9%-27.6%0.390%Search for SEC Filing on Google Icon
5/7/2021Sowell Financial Services LLC2,000$26K0.0%N/A0.014%Search for SEC Filing on Google Icon
3/11/2021swisspartners Ltd.75,000$1.28M1.1%N/A0.539%Search for SEC Filing on Google Icon
2/16/2021HN Saltoro Capital LP15,000$0.26M0.1%N/A0.108%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioVie logo
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Read More on BioVie

Today's Range

Now: $1.90
Low: $1.90
High: $2.13

50 Day Range

MA: $2.67
Low: $1.10
High: $3.51

52 Week Range

Now: $1.90
Low: $1.04
High: $33.10

Volume

1,452,870 shs

Average Volume

1,679,768 shs

Market Capitalization

$33.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of BioVie?

BioVie's top insider investors include:
  1. Steve Gorlin (Director)
  2. Cuong V Do (CEO)
  3. Richard J Berman (Director)
Learn More about top insider investors at BioVie.
This is the worst sign for the U.S. stock market in 50 years
From Stansberry Research   |   Ad
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Click here to see Dan's new, urgent warning about the U.S. market for 2025.